EnerSpar and NurExone Announce Conditional Acceptance of Proposed Reverse Takeover Transaction
- Written by Newsfile
Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") and NurExone Biologic Ltd. ("NurExone") are pleased to announce that the TSX Venture Exchange ("TSXV" or the "Exchange") has conditionally accepted the previously announced reverse takeover transaction (the "RTO") of EnerSpar...